Officials in states and local governments claimed that the opioid crisis was exacerbated by Purdue Pharma’s OxyContin and ...
Potentially $57 million, according to a proposed settlement agreement with the family that once owned Purdue Pharma and has been sued by several states to account for its role in the opioid crisis.
The Sackler dynasty ... those who believed that the family was using their deep pockets to obscure the dark source of their wealth. The family-owned Purdue Pharma became a household name ...
according to a proposed settlement agreement with the family that once owned Purdue Pharma and has been sued by several states to account for its role in the opioid crisis. The Sackler family and ...
State AGs have reached a new opioid settlement worth $7.4 billion with Purdue Pharma and its owners. The settlement does not give Sackler family members immunity from future opioid lawsuits.
Bankrupt Purdue Pharma and its owners have agreed to pay ... members of the billionaire Sackler family, from any further litigation related to the addiction crisis. Thursday’s settlement in ...
In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s ...
The settlement is the largest deal to date with the people primarily who played an “instrumental role” in driving the opioid crisis, according to the office of Massachusetts Attorney General Andrea ...
Jan. 23 (UPI) --The Sackler family and Purdue Pharma have agreed to pay a $7.4 billion settlement to end federal court claims filed by attorneys general on behalf of 15 states. New York Attorney ...
Purdue Pharma and the Sackler family will pay $7.4 billion for their role in the opioid epidemic. Delaware will receive over $27 million from the settlement. The settlement comes just shy of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results